A proposed mechanism for enhanced oxidant production in COVID-19 include downregulating ACE2 after viral attachment leading to an increase in superoxide and hydrogen peroxide produced by angiotensin–II–stimulated NADPH oxidases [49,50]. The gene discussed is FMO5; the disease is COVID-19.